See a summary in our blog post: openrxiv.org/updated-prep...
Quantitative survey results on zenodo: doi.org/10.5281/zeno...
See a summary in our blog post: openrxiv.org/updated-prep...
Quantitative survey results on zenodo: doi.org/10.5281/zeno...
Results from a 2023 survey. N=4,042. Horizontal bar chart of percentage of respondents who value preprints for different reasons. Quality, Impact and Discoverability. To increase awareness of your research, 82%. To benefit science, 64.3%. To control when your research is available, 53.5%. To receive feedback, 37.8%. To increase awareness on social media, 32.5%. Credit and acknowledgement. To stake a priority claim, 55.5%. To cite your research in a grant proposal, 47.9%. To cite research progress in a job application, 30%. To cite your research in a tenure application, 12.8%. Recommendations. Principal/Senior Investigator's recommendation, 24.6%. Comply with funding agency's policy, 21.2%. Co-author recommendation, 15%. Other colleague's recommendation, 9.9%. Other, 5.8%.
The survey results meanwhile reveal authorsβ motivations for preprinting, when they choose to post, how they receive feedback, and the spectrum of authoring tools used.
#preprints #bioRxiv #SurveyResults
Vertical bar plot of number of new papers and revised papers per year and per month from 2013 to 2025. New papers start around 100 per year in 2013-2014. They increase steadily to about 2500 in 2019, with a spike up to 3800 in 2020. They then decrease to about 3000 in 2022 and rise back up to 4000 in 2025. Revised papers follow a similar trend, with the peak to about 1200 in 2020 a decrease and then to 1500 in 2025.
We include an overview of our technological approach and present data on the growth in submissions, revisions, publication outcomes, revisions, withdrawals, license choices, and adoption across different subdisciplines.
#preprints #bioRxiv
β¨ Updated preprint on bioRxiv preprints!
A new version of our preprint summarizes #bioRxiv progress over the last 12 years. This is an update of our original 2019 preprint with new data & highlights from a more recent survey of >7000 users. www.biorxiv.org/content/10.1...
#preprints #OpenScience
@richardsever.bsky.social reflects on the birth of @biorxiv-medrxiv.bsky.social, the crucial role members of the community have played, the experience during the pandemic, & the launch of openRxiv set up to oversee the servers. It truly takes a village.
journals.asm.org/doi/10.1128/...
#OpenScience
In our first year as an independent nonprofit, we grew leadership & collaborations & saw recognition for preprints.
There were also the most new @biorxiv-medrxiv.bsky.social preprints in a year yet! π
Our year in review: openrxiv.org/2025-year-in...
Thank you for continuing to build together. π
How might academia be decentralized?
openRxiv CEO, @tracykteal.bsky.social, joined leaders from arXiv, Feinstein Institutes, and Mount Sinai to explore what decentralization would mean for science.
Watch: www.youtube.com/watch?v=RlNM... #OpenScience #AcademicPublishing
They'll be in this account!
Why the name 're:Port'? re:Port embodies the dynamic exchange of scientific knowledge - replying to and reporting on emerging research while serving as an open portal where discoveries can flow, accelerating the journey from insight to impact.
We're excited to continue sharing the journey. π
Our first issue highlights updates to our DOI, launches of integrations & funder metadata fields, highlights from a recent meeting, and community opportunities.
Read the first issue -> openrxiv.org/wp-content/u...
Introducing the openRxiv re:Port newsletter π¬ π
openRxiv's new newsletter = updates on bioRxiv & medRxiv, new initiatives, & community highlights.
Stay connected on what's next in 'communication at the speed of science'.
Subscribe & view the first issue β openrxiv.org/newsletter/
#OpenScience
openRxiv team members are presentingβbioRxiv and medRxiv: The Next Chapterβ at Cell Bio 2025!
ποΈ Mon, Dec 8
β° 11:15 AM
π Room 117
Come hear whatβs next for preprints + open research. Donβt miss it!
#CellBio2025 #OpenRxiv #ScienceForward #OpenScience #ResearchCommunity
Promotional flyer for openRxiv at Cell Bio 2025, December 6-10 in Philadelphia, PA, booth #1134, with a background of illustrated cells.
openRxiv is heading to Cell Bio 2025 in Philadelphia π¬
See us at Booth 1134 with Cold Spring Harbor Laboratory Press from December 6-10. Weβre excited to meet the community, share what weβre building, and talk about the future of open science. We hope to see you there.
So today on this #GivingTuesday it's a chance to celebrate + support the people and orgs behind open infrastructure.
Donate, volunteer, amplifyβit all counts in supporting and contribute to this work. π
#OpenInfrastructure
But hereβs the paradox: When infrastructure works, it can be invisible.
The better it functions, the easier it is to overlook, especially when itβs time to show support.
#GivingTuesday #OpenScience
...
@cos.io
@investinopen.bsky.social
@orcid.org
@openalexix.bsky.social
They make collaboration + discovery possible.
#OpenSource #OpenData
Just a few of the quiet champions behind open research are orgs like:
@datadryad.bsky.social
@creativecommons.bsky.social
@prereview.bsky.social
@carpentries.carpentries.org
@pyopensci.org
@ropensci.org
@thecscce.bsky.social
@datacite.org
@crossref.bsky.social
...
Scientific open infrastructure is the invisible backbone of research. Itβs what connects scientists across disciplines + borders, builds essential skills, sparks collaboration, and preserves knowledge for future discovery.
#OpenScience #OpenInfrastructure
Photo of a group of 20 people in an open space with windows and desks. People are in a standard group photo pose facing the camera and smiling.
Building trust, building together: In San Diego @continuous.foundation & openRxiv hosted a workshop bringing together developers of scientific communications tools. Implementation focused, and most importantly we got to work together.
Learn more: articles.continuousfoundation.org/articles/sci...
bioRxiv and medRxiv experienced an outage this morning due to the global Cloudflare outage. The sites were unavailable for several hours and may be slow or intermittently unresponsive as services recover. There is no impact on submissions or underlying data. Thank you for your patience.
This pilot expands the @biorxiv-medrxiv.bsky.social review ecosystem alongside bioRxiv/medRxiv to journal transfers, TRiP transparent reviews, @prereview.bsky.social, & @asapbio.bsky.social partnerships.
As preprints decouple dissemination from review, we hope to enable experiments in review.
Founded by molecular biologist @odedrechavi.bsky.social and colleagues, q.e.d. analyzes claims against data, identifies gaps, and highlights original contributions, typically delivering detailed reports for authors in ~30 minutes.
Enabling options for review: bioRxiv authors now have the option to send their preprints directly to @qedscience.bsky.social , an authors-centered AI review platform, for automated feedback on their paper.
openrxiv.org/enabling-rev...
#OpenScience #Preprints #openrxiv #qedscience #biorxiv
openRxivβs @richardsever.bsky.social, recently participated in a panel discussion on open science and trust in research hosted by the Shorenstein Center on Media, Politics and Public Policy.
Watch here: β‘οΈ www.youtube.com/watch?v=myYp...
#openscience #openrxiv #biorxiv #medrxiv
This role presents an opportunity to shape how scientific research is shared globally. If you're interested in making cutting-edge research freely accessible and working at the intersection of science and technology, we'd love to hear from you. π
More info and how to apply: openrxiv.org/careers/
Experience navigating uncertainty, working effectively with open-source communities, and expertise in striking a balance between strategic thinking and hands-on execution are must haves.
We're seeking an individual with experience in product management and team leadership, knowledge of digital scientific publishing, and the ability to work effectively in a fully remote environment.
π€ Work directly with our CEO and Chief Science & Strategy Officer to set organizational direction and roadmapping
π Contribute to the foundational groundwork for openRxiv's future success and growth
π‘ And more!
What you would get to do:
π₯ Lead our technical team to continue running bioRxiv and medRxiv, including documentation and development practices, and identify areas for increased efficiency
π¬ Build products and services that advance scientific communication
We oversee bioRxiv and medRxiv, which together post over 62,000 preprints annually, transforming how scientific discoveries are shared worldwide.